View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
Sponsored by Avance Clinical

Avance Clinical – ClinicReady Case Study

Free White Paper

Avance Clinical – ClinicReady Case Study

By Avance Clinical

Avance Clinical – ClinicReady Case Study

By Avance Clinical
Enter your details to receive the free paper:

Tetherex Pharmaceuticals is developing a single-cycle adenoviral vector vaccine for the treatment of Covid-19.

The treatment is designed for intranasal delivery, which is expected to provide a more efficient front-line defence against Covid-19 in airway tissues, the site of virus entry into the body. The vaccine is currently undergoing safety testing in healthy volunteers.

To read more, please download this free white paper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology